Literature DB >> 1439857

[Treatment of gas gangrene. Results of a retro- and prospective analysis of a traumatologic patient sample over 20 years].

M Erttmann1, D Havemann.   

Abstract

From 1970 to 1977 and from 1978 to 1990, the treatment and outcome in 136 patients with gas gangrene were investigated. The prognosis was better in patients with gas gangrene after trauma than in patients with gas gangrene resulting from vascular insufficiency or malignant tumours. In the first group the lethality of gas gangrene was 28.6%, in the second group, 7.1%. This difference is significant (P < 0.05). In 40.5% the infected extremities were saved. Patients with injuries without fractures did not lose limbs because of gas gangrene or die of it. When an operation was performed before or after the first session of oxygenation at high pressure (OHP) lethality was lower (20%) and the rate of saved limbs higher (80%) than with later operation (lethality, 50%; saved limbs, 45.5%). All patients who could not be treated by OHP, or only once or twice, died. From 1970 to 1977 patients who were treated surgically and received OHP for 5 days survived, and since 1978 this has applied to patients treated for 4 days. In general, the lives of patients with gas gangrene are no longer in danger by the 5th day of therapy. The use of checklists for diagnosis and therapy has been practised since 1978, and this is assumed to be one factor in the better outcome.

Entities:  

Mesh:

Year:  1992        PMID: 1439857

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  3 in total

1.  Improved vacuum sealing drainage in the treatment of gas gangrene: a case report.

Authors:  Zhaofa Liu; Dewei Zhao; Benjie Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  [Gas gangrene of the hand. A case report].

Authors:  T Peterson; H Wissing
Journal:  Unfallchirurgie       Date:  1994-08

Review 3.  [Hyperbaric oxygenation for necrotizing soft tissue infections: pro].

Authors:  M Schmale; A Fichtner; C Pohl; E John; M Bucher
Journal:  Chirurg       Date:  2012-11       Impact factor: 0.955

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.